Rv0667 - c.387C>G
Drug resistance types
5 Sensitive
1 RR-TB
16 HR-TB
2 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
15 Other
lineage Counts
| lineage | Count |
|---|---|
| 17 | |
| lineage4.9 | 14 |
| lineage4.2.1 | 1 |
| lineage4;lineage2.2 | 1 |
| lineage4 | 2 |
| lineage2.2.1 | 1 |
| lineage4.4.2;lineage2.2.1 | 1 |
| lineage4.2.1.1 | 1 |
| lineage1.2.2.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 39 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR3675550 | Other | None | ERR4815471 | Other | lineage4.9 | None | ERR4816964 | Other | lineage4.9 | None | ERR4818710 | Sensitive | lineage4.9 | None | ERR1035162 | Other | None | SRR5341418 | Other | None | ERR4819357 | Other | lineage4.9 | None | SRR6046460 | HR-TB | None | ERR1023509 | Other | None | ERR4819933 | Other | lineage4.9 | None | SRR6045664 | Other | lineage4.2.1 | None | SRR6046362 | HR-TB | None | SRR6046824 | HR-TB | None | SRR6046482 | HR-TB | None | ERR4831792 | MDR-TB | lineage4;lineage2.2 | None | ERR323037 | HR-TB | lineage4 | None | ERR485006 | HR-TB | lineage4.9 | None | ERR4831825 | HR-TB | lineage2.2.1 | None | ERR067681 | HR-TB | None | ERR4831841 | HR-TB | lineage4.4.2;lineage2.2.1 | None | SRR6832178 | HR-TB | lineage4.2.1.1 | None | ERR502889 | Other | None | ERR133986 | HR-TB | None | ERR1034652 | Other | None | ERR4797350 | Sensitive | lineage4.9 | None | ERR403298 | HR-TB | lineage4 | None | ERR473367 | Sensitive | lineage4.9 | None | ERR4797285 | MDR-TB | lineage1.2.2.2 | None | ERR3439432 | Other | None | ERR473303 | Sensitive | lineage4.9 | None | ERR473334 | HR-TB | lineage4.9 | None | SRR16156804 | RR-TB | lineage4.9 | None | ERR4798406 | HR-TB | None | ERR4812155 | Sensitive | None | ERR6359070 | Other | lineage4.9 | None | ERR6359069 | Other | lineage4.9 | None | ERR736831 | HR-TB | lineage4.9 | None | ERR158583 | HR-TB | None | SRR3675502 | Other | None |
|---|
